What is LOPJLB’s current signal on BDSX?

LOPJLB’s latest quantitative signal on Biodesix, Inc. (BDSX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is BDSX in?

Biodesix, Inc. (BDSX) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Biodesix, Inc. (BDSX) do?

Biodesix, Inc. is a data-driven diagnostic solutions provider operating across the United States. Its primary focus includes a comprehensive suite of blood-based lung tests, marketed as the Nodify Lung Nodule Risk Assessment (which includes Nodify XL2 and Nodify CDT). These assessments enable clinicians to evaluate the risk of lung cancer in patients with suspicious nodules, aiding in the recla…

Where is Biodesix, Inc. based / listed?

Biodesix, Inc. is based in US, listed on NASDAQ.

Biodesix, Inc. (BDSX)

COMPARE

Healthcare · Medical - Diagnostics & Research · NASDAQ · US

$25.63-2.99%Close

SELLCRISIS · day 2

[SCORES & PROFILE]

FUND: 0
VALUE: 0
GROWTH: 31
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-

REV YoY-

ROE-

EPS YoY-

ROA-29.1%

GROSS

-20

NET

-27

[VALUATION]

P/E TTM-8.82

P/E FWD-

SECTOR PE20.12

INDUSTRY PE30.72

P/B31.48

P/FCF-

EV/EBITDA-18.87

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E785.17

ALTMAN Z-

CURR RATIO2.85

ND/EBITDA-

BETA0.55

Biodesix, Inc. (BDSX)

Key stats

Prediction markets

FUNDAMENTALS

Company news